Skip to content

North Guangdong region of congenital heart disease epidemic situation and influencing factors of cohort study

North Guangdong region of congenital heart disease epidemic situation and influencing factors of cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-EOC-17011163
Enrollment
Unknown
Registered
2017-04-17
Start date
2017-04-26
Completion date
Unknown
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital heart disease

Interventions

Case group:Health education

Sponsors

The fifth affiliated hospital of southern medical university
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: First stage: on September 1, 2016 - August 31, 2018, four cities in north guangdong area county hospitals, all pregnant women, prenatal acuity 16 week of gestation in the obstetric outpatient registration. The second stage: on September 1, 2016 - August 31, 2018, four cities in north guangdong area county hospital antenatal examination of husband and wife, according to the prenatal fetal cardiac ultrasound and born after pediatric cardiac ultrasound diagnosis of congenital heart disease or autopsy cases of pregnant women as a group. Promote education, fill in the north guangdong region of congenital heart disease risk research questionnaire. The third stage: on September 1, 2018 to August 31, 2020, at the same time around the cities and counties in four hospitals in antenatal examination of husband and wife, according to the prenatal fetal echocardiogram and after pediatric cardiac ultrasound diagnosis of congenital heart disease or autopsy cases of pregnant women as a group. Promote education, fill in the congenital heart disease exposure factors questionnaire.

Exclusion criteria

Exclusion criteria: First stage: don't agree to participate in the study of pregnant women; Signed the informed consent but not screening diagnosis and the abortion of pregnant women; Hard to track the pregnancy outcomes of pregnant women. The second stage: don't agree to participate in the study of pregnant women; Signed the informed consent but not screening diagnosis and the abortion of pregnant women; Hard to track the pregnancy outcomes of pregnant women. The third stage: don't agree to participate in the study of pregnant women; Signed the informed consent but not screening diagnosis and the abortion of pregnant women; Hard to track the pregnancy outcomes of pregnant women.

Design outcomes

Primary

MeasureTime frame
Ultrasound Cardiogram;Incidence of congenital heart disease;Congenital heart disease risk factors;Congenital heart disease protection factors;

Secondary

MeasureTime frame
SPO2;PI;

Countries

China

Contacts

Public ContactZou Xiaoming

The fifth affiliated hospital of southern medical university

zouxm999@163.com+86 13902266121

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026